270 related articles for article (PubMed ID: 8613461)
1. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
2. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
3. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
6. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
Marczin N; Ryan US; Catravas JD
J Pharmacol Exp Ther; 1992 Oct; 263(1):170-9. PubMed ID: 1328604
[TBL] [Abstract][Full Text] [Related]
8. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
Hu ZW; Honda K; Murad F; Hoffman BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):756-61. PubMed ID: 1346644
[TBL] [Abstract][Full Text] [Related]
10. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells.
Ujiie K; Hogarth L; Danziger R; Drewett JG; Yuen PS; Pang IH; Star RA
J Pharmacol Exp Ther; 1994 Aug; 270(2):761-7. PubMed ID: 7915320
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to sodium nitroprusside. Studies in cultured porcine vascular smooth muscle cells.
Zhang LM; Castresana MR; Stefansson S; Newman WH
Anesthesiology; 1993 Nov; 79(5):1094-103. PubMed ID: 8238986
[TBL] [Abstract][Full Text] [Related]
12. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
Zhang Y; Islam M; Akhtar RA
Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
14. [Vasodilator drugs that act by stimulating guanylate cyclase in vascular smooth muscle].
Castillo C; Hong E
Arch Inst Cardiol Mex; 1991; 61(4):375-84. PubMed ID: 1683218
[TBL] [Abstract][Full Text] [Related]
15. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
16. Different effects of soluble and particulate guanylyl cyclases on expression of inflammatory cytokines in rat peripheral blood mononuclear cells.
Mitkiewicz M; Kuropatwa M; Kurowska E; Gorczyca WA
Immunobiology; 2011 Mar; 216(3):423-30. PubMed ID: 20656372
[TBL] [Abstract][Full Text] [Related]
17. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.
Nakane M; Hsieh G; Miller LN; Chang R; Terranova MA; Moreland RB; Kolasa T; Brioni JD
Int J Impot Res; 2002 Apr; 14(2):121-7. PubMed ID: 11979328
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic changes in rat and guinea pig coronary microvascular endothelium after culture: loss of nitric oxide synthase activity.
Lang D; Bell JP; Bayraktutan U; Small GR; Shah AM; Lewis MJ
Cardiovasc Res; 1999 Jun; 42(3):794-804. PubMed ID: 10533620
[TBL] [Abstract][Full Text] [Related]
20. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
